- Home
- CGEM vs REPX Comparison
CGEM vs REPX Comparison
Compare CGEM & REPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- REPX
- Stock Information
- Founded
- CGEM 2016
- REPX 2016
- Country
- CGEM United States
- REPX United States
- Employees
- CGEM N/A
- REPX N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- REPX Oil & Gas Production
- Sector
- CGEM Health Care
- REPX Energy
- Exchange
- CGEM Nasdaq
- REPX Nasdaq
- Market Cap
- CGEM 530.0M
- REPX 588.9M
- IPO Year
- CGEM 2021
- REPX N/A
- Fundamental
- Price
- CGEM $8.18
- REPX $26.62
- Analyst Decision
- CGEM Strong Buy
- REPX Strong Buy
- Analyst Count
- CGEM 6
- REPX 1
- Target Price
- CGEM $28.17
- REPX $47.00
- AVG Volume (30 Days)
- CGEM 331.3K
- REPX 144.5K
- Earning Date
- CGEM 08-07-2025
- REPX 08-06-2025
- Dividend Yield
- CGEM N/A
- REPX 5.70%
- EPS Growth
- CGEM N/A
- REPX N/A
- EPS
- CGEM N/A
- REPX 4.67
- Revenue
- CGEM N/A
- REPX $412,894,000.00
- Revenue This Year
- CGEM N/A
- REPX $2.85
- Revenue Next Year
- CGEM N/A
- REPX $4.05
- P/E Ratio
- CGEM N/A
- REPX $5.70
- Revenue Growth
- CGEM N/A
- REPX 1.25
- 52 Week Low
- CGEM $6.85
- REPX $21.98
- 52 Week High
- CGEM $20.96
- REPX $37.55
- Technical
- Relative Strength Index (RSI)
- CGEM 54.88
- REPX 48.39
- Support Level
- CGEM $7.42
- REPX $24.92
- Resistance Level
- CGEM $8.70
- REPX $27.66
- Average True Range (ATR)
- CGEM 0.38
- REPX 1.08
- MACD
- CGEM 0.09
- REPX -0.02
- Stochastic Oscillator
- CGEM 63.12
- REPX 48.85
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About REPX Riley Exploration Permian Inc.
Riley Exploration Permian Inc is engaged in the business of exploration for and production of oil and natural gas. The company operations are in Kansas Properties and Tennessee Properties, among others.